Back to Authors

Zhen, Huiling

Mayo Clinic

Incyte (United States)

Citations 1

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

Future Oncology | July 17, 2020 | Volume: 16 | Issue: 30 | Pages: 2385-2399

10.2217/fon-2020-0429 | PMID 32677452